Aurinia Pharmaceuticals Inc (AUPH)
5.10
-0.07
(-1.35%)
USD |
NASDAQ |
May 03, 16:00
5.095
0.00 (0.00%)
After-Hours: 20:00
Aurinia Pharmaceuticals Cash from Operations (Quarterly): 14.31M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 14.31M |
| September 30, 2023 | -13.28M |
| June 30, 2023 | -2.826M |
| March 31, 2023 | -31.67M |
| December 31, 2022 | 10.45M |
| September 30, 2022 | -15.36M |
| June 30, 2022 | -27.87M |
| March 31, 2022 | -46.75M |
| December 31, 2021 | -25.92M |
| September 30, 2021 | -40.25M |
| June 30, 2021 | -37.98M |
| March 31, 2021 | -53.54M |
| December 31, 2020 | 3.204M |
| September 30, 2020 | -28.42M |
| June 30, 2020 | -22.04M |
| March 31, 2020 | -22.61M |
| December 31, 2019 | -25.41M |
| September 30, 2019 | -11.78M |
| June 30, 2019 | -13.25M |
| March 31, 2019 | -13.15M |
| December 31, 2018 | -13.62M |
| September 30, 2018 | -11.33M |
| June 30, 2018 | -12.29M |
| March 31, 2018 | -14.38M |
| December 31, 2017 | -8.931M |
| Date | Value |
|---|---|
| September 30, 2017 | -8.525M |
| June 30, 2017 | -14.00M |
| March 31, 2017 | -9.715M |
| December 31, 2016 | -4.26M |
| September 30, 2016 | -4.188M |
| June 30, 2016 | -5.045M |
| March 31, 2016 | -5.22M |
| December 31, 2015 | -4.838M |
| September 30, 2015 | -5.209M |
| June 30, 2015 | -3.697M |
| March 31, 2015 | -4.022M |
| December 31, 2014 | -3.348M |
| September 30, 2014 | -4.024M |
| June 30, 2014 | -4.182M |
| March 31, 2014 | -5.354M |
| December 31, 2013 | -2.553M |
| September 30, 2013 | -1.485M |
| June 30, 2013 | -0.381M |
| March 31, 2013 | -0.201M |
| December 31, 2012 | -0.779M |
| September 30, 2012 | -1.243M |
| June 30, 2012 | -2.714M |
| March 31, 2012 | -1.811M |
| December 31, 2011 | -1.242M |
| September 30, 2011 | -1.213M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-53.54M
Minimum
Mar 2021
14.31M
Maximum
Dec 2023
-20.58M
Average
-22.61M
Median
Mar 2020
Cash from Operations (Quarterly) Benchmarks
| Lexaria Bioscience Corp | -0.6196M |
| Acasti Pharma Inc | -1.892M |
| Edesa Biotech Inc | -1.406M |
| Xenon Pharmaceuticals Inc | -35.46M |
| ESSA Pharma Inc | -6.787M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -6.257M |
| Cash from Financing (Quarterly) | -5.577M |
| Free Cash Flow | -34.18M |
| Free Cash Flow Per Share (Quarterly) | 0.0992 |
| Free Cash Flow to Equity (Quarterly) | 14.25M |
| Free Cash Flow to Firm (Quarterly) | 14.25M |
| Free Cash Flow Yield | -4.69% |